Yasunari Nakamoto

Anti-Kv1.4 Antibody-positive Nivolumab-induced Myasthenia Gravis and Myositis Presenting with Bilateral Ptosis and Demonstrating Different Pathophysiologies

M. Ikawa, T. Hamano, O. Yamamura, 2023, Internal medicine.

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.

A. Gasbarrini, B. Sands, I. Lawrance, 2023, Gastroenterology.

Tubulointerstitial Nephritis with IgM-Positive Plasma Cells.

I. Narita, K. Sada, C. Munemura, 2017, Journal of the American Society of Nephrology : JASN.

Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus

M. Kurosaki, K. Matsuura, Y. Hiasa, 2023, Journal of Gastroenterology.

Changes of circulating tumor cells expressing CD90 and EpCAM in early-phase of atezolizumab and bevacizumab for hepatocellular carcinoma

M. Ohtani, Yu Akazawa, Tatsushi Naito, 2024, Heliyon.